Loading quotes...

Forecast

The analysts' average price target is €2.83 (+141.88%). The median is €3.12 (+166.67%).

Buy	5
Hold	1
Sell	1

News Go to news feed

Aemetis reports Q2 revenue up 20% as RNG and ethanol projects drive results

Aemetis posted Q2 2026 revenue of $62.7 million, up 20% year‑over‑year, with operating income improving to $5.8 million and net loss narrowing to $9.4 million; adjusted EBITDA rose to $9.7 million. Section 45Z production tax credits contributed $8.6 million and recent California LCFS pathway approvals materially increase the value of dairy RNG sales. Management highlighted near‑term milestones including two additional dairy digesters, completion of an MVR energy‑efficiency project at the Keyes ethanol plant expected to boost annual cash flow by about $32 million, doubled corn oil recovery capacity, and India biodiesel allocations expected to generate roughly $17 million in revenue. » More on finance.yahoo.com
Aemetis cuts loss in Q2 2026 but misses revenue forecast

Aemetis reported Q2 2026 revenue growth of 20% to $62.7 million, but came in about 10.3% below analysts’ expectations. Adjusted loss per share improved to a loss of $0.13 (expected -$0.26) and adjusted EBITDA turned positive at $9.7 million; operating income rose to $5.8 million. The company highlighted liquidity gains from Section 45Z tax credits, but cites only $1 million in cash, high debt and dependence on regulatory credits as risks; the MVR project and LCFS/India businesses are expected to strengthen future cash flows. » More on de.investing.com
Aemetis reports biodiesel supply contract for India worth about $17 million

Aemetis shares rose after its subsidiary Universal Biofuels secured supply contracts worth about $17 million. Universal Biofuels is to deliver more than 18 million liters of biodiesel within three months to three state oil marketing companies in India, supporting the national biofuel strategy. The unit operates a plant in Kakinada with an annual capacity of around 80 million gallons and uses a proprietary enzymatic process; additional supply orders are expected before the end of 2026. Universal Biofuels is evaluating expansion opportunities in India, including biogas from dairy waste, ethanol, a sustainable aviation fuel project and a possible IPO. » More on de.investing.com

Financials

In the last quarter, Aemetis had revenue of €54.94m and net profit of -€8.21m

(EUR)	June 2026	YoY
Revenue	54.94m	23.95%
Gross profit	11.84m	516.03%
Net profit	-8.21m	58.65%
EBITDA	-5.98m	2.15%

Fundamentals

Metric	Value
Market capitalization	€83.64m
Number of shares	72.17m
52-week high/low	€3.39 - €1.05
Dividends	No
Beta	1.47
P/E ratio	-1.43
PEG ratio	-0.02
P/B ratio	-0.29
P/S ratio	0.41

Company profile

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products. It sells biodiesel primarily to government oil marketing companies, transport companies, resellers, distributors, and private refiners through its own sales force and independent sales agents, as well as to brokers who resell the product to end-users. The company also produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. In addition, it produces dairy biogas; produces and sells high-grade alcohol and various feed products, as well as hand sanitizers; and researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.